Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI vs H2RA with CHOP in DLBCL
NCT03647072Phase 3Recruiting
- Start
- Aug 2018
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole, famotidine in diffuse large B-cell lymphoma (DLBCL). Started Aug 2018; status: recruiting.
02
Drugs
lansoprazolefamotidine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03647072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03647072.